OBJECTIVES: To test the effectiveness of a step-by step, evidence-based guide, the 4 Pillars Practice Transformation Program, to increase adult pneumococcal vaccination. DESIGN: Randomized controlled cluster trial (RCCT) in Year 1 (June 1, 2013 to May 31, 2014) and pre-post study in Year 2 (June 1, 2014 to January 31, 2015) with data analyzed in 2016. Baseline year was June 1, 2012, to May 31, 2013. Demographic and vaccination data were derived from deidentified electronic medical record extractions. SETTING:Primary care practices (n = 25) stratified according to metropolitan area (Houston, Pittsburgh), location (rural, urban, suburban), and type (family medicine, internal medicine), randomized to receive the intervention in Year 1 (n = 13) or Year 2 (n = 12). PARTICIPANTS: Individuals aged 65 and older at baseline (N = 18,107; mean age 74.2; 60.7% female, 16.5% non-white, 15.7% Hispanic). INTERVENTION: The 4 Pillars Program, provider education, and one-on-one coaching of practice-based immunization champions. Outcome measures were 23-valent pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV) vaccination rates and percentage point (PP) changes in vaccination rates. RESULTS: In the Year 1 RCCT, PPSV vaccination rates increased significantly in all intervention and control groups, with average increases ranging from 6.5 to 8.7 PP (P < .001). The intervention was not related to greater likelihood of PPSV vaccination. In the Year 2 pre-post study, the likelihood of PPSV and PCV vaccination was significantly higher in the active intervention sites than the maintenance sites in Pittsburgh but not in Houston. CONCLUSION: In a RCCT, PPSV vaccination rates increased in the intervention and control groups in Year 1. In a pre-post study, private primary care practices actively participating in the 4Pillars Practice Transformation Program improved PPSV and PCV uptake significantly more than practices that were in the maintenance phase of the study.
RCT Entities:
OBJECTIVES: To test the effectiveness of a step-by step, evidence-based guide, the 4 Pillars Practice Transformation Program, to increase adult pneumococcal vaccination. DESIGN: Randomized controlled cluster trial (RCCT) in Year 1 (June 1, 2013 to May 31, 2014) and pre-post study in Year 2 (June 1, 2014 to January 31, 2015) with data analyzed in 2016. Baseline year was June 1, 2012, to May 31, 2013. Demographic and vaccination data were derived from deidentified electronic medical record extractions. SETTING: Primary care practices (n = 25) stratified according to metropolitan area (Houston, Pittsburgh), location (rural, urban, suburban), and type (family medicine, internal medicine), randomized to receive the intervention in Year 1 (n = 13) or Year 2 (n = 12). PARTICIPANTS: Individuals aged 65 and older at baseline (N = 18,107; mean age 74.2; 60.7% female, 16.5% non-white, 15.7% Hispanic). INTERVENTION: The 4 Pillars Program, provider education, and one-on-one coaching of practice-based immunization champions. Outcome measures were 23-valent pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV) vaccination rates and percentage point (PP) changes in vaccination rates. RESULTS: In the Year 1 RCCT, PPSV vaccination rates increased significantly in all intervention and control groups, with average increases ranging from 6.5 to 8.7 PP (P < .001). The intervention was not related to greater likelihood of PPSV vaccination. In the Year 2 pre-post study, the likelihood of PPSV and PCV vaccination was significantly higher in the active intervention sites than the maintenance sites in Pittsburgh but not in Houston. CONCLUSION: In a RCCT, PPSV vaccination rates increased in the intervention and control groups in Year 1. In a pre-post study, private primary care practices actively participating in the 4 Pillars Practice Transformation Program improved PPSV and PCV uptake significantly more than practices that were in the maintenance phase of the study.
Authors: Richard K Zimmerman; Steven M Albert; Mary Patricia Nowalk; Michael A Yonas; Faruque Ahmed Journal: Am J Prev Med Date: 2011-02 Impact factor: 5.043
Authors: Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson Journal: Ann Fam Med Date: 2012 Nov-Dec Impact factor: 5.166
Authors: Erin Fries Taylor; Rachel M Machta; David S Meyers; Janice Genevro; Deborah N Peikes Journal: Ann Fam Med Date: 2013 Jan-Feb Impact factor: 5.166
Authors: Tammy A Santibanez; Richard Kent Zimmerman; Mary Patricia Nowalk; Ilene Katz Jewell; Inis J Bardella Journal: Ann Fam Med Date: 2004 Jan-Feb Impact factor: 5.166
Authors: Richard K Zimmerman; Mary Patricia Nowalk; Mahlon Raymund; Melissa Tabbarah; David G Hall; J Todd Wahrenberger; Stephen A Wilson; Edmund M Ricci Journal: Am J Public Health Date: 2003-10 Impact factor: 9.308
Authors: Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; Carolyn B Bridges; David K Kim; Tamara Pilishvili; Craig M Hales; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-06 Impact factor: 17.586
Authors: Mary Patricia Nowalk; Krissy K Moehling; Song Zhang; Jonathan M Raviotta; Richard K Zimmerman; Chyongchiou J Lin Journal: Am J Manag Care Date: 2017-11 Impact factor: 2.229
Authors: Richard K Zimmerman; Jonathan M Raviotta; Mary Patricia Nowalk; Krissy K Moehling; Evelyn Cohen Reis; Sharon G Humiston; Chyongchiou Jeng Lin Journal: Vaccine Date: 2017-09-22 Impact factor: 3.641
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Mary Patricia Nowalk; Chyongchiou J Lin; Valory N Pavlik; Anthony E Brown; Song Zhang; Krissy K Moehling; Jonathan M Raviotta; Jeannette E South-Paul; Mary Hawk; Edmund M Ricci; Donald B Middleton; Suchita A Patel; Faruque Ahmed; Richard K Zimmerman Journal: Vaccine Date: 2016-08-26 Impact factor: 3.641
Authors: Angela R Wateska; Mary Patricia Nowalk; Chyongchiou J Lin; Lee H Harrison; William Schaffner; Richard K Zimmerman; Kenneth J Smith Journal: J Am Geriatr Soc Date: 2020-02-22 Impact factor: 5.562